NATCO Pharma Management
Management Kriterienprüfungen 4/4
NATCO Pharma's CEO ist Rajeev Nannapaneni, ernannt in Jun 2012, hat eine Amtszeit von 11.92 Jahren. besitzt direkt 0.63% der Aktien des Unternehmens, im Wert von ₹1.15B. Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 7.3 Jahre bzw. 9.4 Jahre.
Wichtige Informationen
Rajeev Nannapaneni
Geschäftsführender
₹20.9m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | n/a |
| Amtszeit als Geschäftsführer | 12.1yrs |
| Eigentum des Geschäftsführers | 0.6% |
| Durchschnittliche Amtszeit des Managements | 7.4yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 9.5yrs |
Jüngste Management Updates
Recent updates
NATCO Pharma (NSE:NATCOPHARM) Seems To Use Debt Rather Sparingly
Jun 30
NATCO Pharma Limited's (NSE:NATCOPHARM) Earnings Are Not Doing Enough For Some Investors
Jun 14NATCO Pharma Limited (NSE:NATCOPHARM) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
May 30Calculating The Fair Value Of NATCO Pharma Limited (NSE:NATCOPHARM)
May 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Apr 03NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25
Feb 21NATCO Pharma Limited Just Beat EPS By 223%: Here's What Analysts Think Will Happen Next
Feb 18NATCO Pharma Limited (NSE:NATCOPHARM) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Feb 17Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jan 25An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 37% Undervalued
Jan 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Dec 13An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 42% Undervalued
Sep 30Here's Why We Think NATCO Pharma (NSE:NATCOPHARM) Might Deserve Your Attention Today
Sep 12NATCO Pharma (NSE:NATCOPHARM) Is Paying Out A Larger Dividend Than Last Year
Aug 12Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jul 16NATCO Pharma Limited (NSE:NATCOPHARM) Shares Could Be 44% Below Their Intrinsic Value Estimate
Apr 20Is NATCO Pharma Limited (NSE:NATCOPHARM) Trading At A 46% Discount?
Dec 20NATCO Pharma's (NSE:NATCOPHARM) Upcoming Dividend Will Be Larger Than Last Year's
Aug 12Does NATCO Pharma (NSE:NATCOPHARM) Have A Healthy Balance Sheet?
Jun 23Broker Revenue Forecasts For NATCO Pharma Limited (NSE:NATCOPHARM) Are Surging Higher
Jun 02NATCO Pharma's (NSE:NATCOPHARM) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 22Estimating The Intrinsic Value Of NATCO Pharma Limited (NSE:NATCOPHARM)
Feb 16Here's Why NATCO Pharma (NSE:NATCOPHARM) Has A Meaningful Debt Burden
Nov 30Geschäftsführer
Rajeev Nannapaneni (47 yo)
12.1yrs
Amtszeit
₹20,920,000
Vergütung
Sri Rajeev Nannapaneni serves as Chief Executive Officer at NATCO Pharma Limited since April 1, 2022 and also served as Vice Chairman since June 1, 2012 until April 1, 2022 and serves as its Vice Chairman...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| MD & Chairman | 42.8yrs | ₹22.68m | 25.1% ₹ 53.6b | |
| CEO & Vice Chairman | 12.1yrs | ₹20.92m | 0.63% ₹ 1.3b | |
| Chief Financial Officer | 8.4yrs | ₹13.00m | keine Daten | |
| President of Technical Affairs & Whole Time Director | no data | ₹32.30m | 0.030% ₹ 64.6m | |
| Company Secretary & Compliance Officer | 2.3yrs | ₹3.00m | keine Daten | |
| Executive VP of Corporate Engineering Services & Whole Time Director | no data | ₹19.20m | 0.023% ₹ 49.0m | |
| Executive VP of Technical Operations & Director | 7.4yrs | ₹54.50m | keine Daten | |
| Senior Vice President of Operations | no data | keine Daten | keine Daten | |
| Executive Vice President of Corporate Affairs | no data | keine Daten | keine Daten | |
| Vice President of Marketing & Sales - Domestic | less than a year | keine Daten | keine Daten | |
| Senior Vice President of HR & Organisational Development | no data | keine Daten | 0.0062% ₹ 13.2m | |
| Executive Vice President of R&D | 30.3yrs | keine Daten | keine Daten |
7.4yrs
Durchschnittliche Betriebszugehörigkeit
65yo
Durchschnittliches Alter
Erfahrenes Management: Das Managementteam von NATCOPHARM ist erfahren und erfahren (durchschnittliche Amtszeit: 7.3 Jahre).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| MD & Chairman | 42.8yrs | ₹22.68m | 25.1% ₹ 53.6b | |
| CEO & Vice Chairman | 18.7yrs | ₹20.92m | 0.63% ₹ 1.3b | |
| President of Technical Affairs & Whole Time Director | 9.4yrs | ₹32.30m | 0.030% ₹ 64.6m | |
| Executive VP of Corporate Engineering Services & Whole Time Director | 9.7yrs | ₹19.20m | 0.023% ₹ 49.0m | |
| Executive VP of Technical Operations & Director | 1.9yrs | ₹54.50m | keine Daten | |
| Independent Director | 10.3yrs | ₹620.00k | keine Daten | |
| Independent Director | 9.8yrs | ₹350.00k | keine Daten | |
| Independent Director | 9.4yrs | ₹600.00k | keine Daten | |
| Independent Director | less than a year | keine Daten | keine Daten | |
| Independent Director | less than a year | keine Daten | keine Daten |
9.5yrs
Durchschnittliche Betriebszugehörigkeit
69yo
Durchschnittliches Alter
Erfahrener Vorstand: NATCOPHARMDie Vorstandsmitglieder gelten als erfahren (9.4 Jahre durchschnittliche Amtszeit).